Chemicals · Founded 1979 · www.lordschloro.com · BSE 500284 · NSE LORDS CHLORO · ISIN INE846D01012
No Notes Added Yet
Business
Lords Chloro Alkali Ltd. is an Indian chemical manufacturer primarily engaged in the production of Chlor-Alkali products. Its core business involves the electrolysis of brine (saltwater) to produce Caustic Soda (in liquid lye and flake forms), Liquid Chlorine, and their derivatives such as Hydrochloric Acid (HCL), Sodium Hypochlorite, and Stable Bleaching Powder (SBP). The company operates a manufacturing facility in Rajasthan, India, utilizing energy-efficient membrane cell technology. It generates revenue by supplying these essential chemicals as industrial inputs to various sectors including alumina, pulp & paper, textiles, soaps & detergents, water treatment, PVC, pharmaceuticals, and agrochemicals.
Revenue Mix
The company's business is largely integrated around the Chlor-Alkali manufacturing process. While specific revenue contribution percentages for individual products are not typically detailed as distinct segments, the primary revenue streams are derived from:
Caustic Soda: The largest contributor, sold as Caustic Soda Lye and Caustic Soda Flakes.
Chlorine and its Derivatives: Including Liquid Chlorine, Hydrochloric Acid (HCL), Sodium Hypochlorite, and Stable Bleaching Powder (SBP), which utilize the co-produced chlorine from the caustic soda manufacturing.
Industry
The Indian Chlor-Alkali industry is a capital-intensive and power-intensive sector, making power cost a critical determinant of profitability. It is cyclical, driven by demand from key end-user industries and global supply-demand dynamics. The industry is characterized by the presence of a few large players (e.g., Grasim Industries, Gujarat Alkalies and Chemicals Ltd. - GACL) and several mid-to-small scale producers. Lords Chloro Alkali Ltd. is positioned as a smaller to mid-sized player, primarily serving regional markets from its facility. While it employs modern membrane cell technology for efficiency, it faces competition from larger, often more integrated players who benefit from greater economies of scale and wider geographic reach.
MOAT
Operational Efficiency: The company utilizes energy-efficient membrane cell technology, which provides a cost advantage over older, less efficient production methods. The integrated production of chlorine derivatives helps in efficient utilization of co-produced chlorine, reducing waste and enhancing value.
Regional Presence: Its manufacturing location in Rajasthan may offer a logistical advantage and proximity to certain regional customers or raw material sources, potentially reducing transportation costs for those clients.
Customer Relationships: For commodity chemicals, long-standing relationships and consistent product quality can foster some customer stickiness, though switching costs are generally moderate.
Overall, the company's competitive advantages are modest, primarily stemming from efficient operations and a focused regional market presence, rather than strong brand equity, proprietary technology, or significant network effects.
Growth Drivers
1. Industrial Demand Growth: Continued industrialization and expansion across key end-user sectors in India (e.g., alumina, textiles, pulp & paper, water treatment, PVC, agrochemicals) will drive sustained demand for caustic soda and chlorine derivatives.
2. Capacity Utilization & Expansion: Optimization of existing capacity utilization and potential future capacity expansions or debottlenecking initiatives could lead to increased sales volumes.
3. Operational Efficiencies: Ongoing focus on reducing power consumption and other input costs can improve margins and profitability, especially crucial in this power-intensive industry.
4. Infrastructure Development: Government thrust on infrastructure and manufacturing in India is expected to indirectly boost demand for core chemicals.
Risks
1. Raw Material & Power Price Volatility: Significant fluctuations in the prices of key inputs such as common salt and, critically, electricity (which constitutes a major portion of operating costs), can severely impact profitability.
2. Industry Cyclicality: The Chlor-Alkali business is inherently cyclical, with demand and pricing heavily influenced by the macroeconomic environment and health of end-user industries, leading to revenue and profit volatility.
3. Intense Competition: The presence of larger, more established players with greater economies of scale and bargaining power poses a constant competitive threat, potentially affecting pricing power and market share.
4. Environmental & Regulatory Risks: Stringent and evolving environmental regulations concerning chemical production, waste management, and energy consumption could lead to increased compliance costs or operational restrictions.
5. Technology Obsolescence: While currently using modern membrane cell technology, any significant technological advancements by competitors could necessitate further capital expenditure.
Management & Ownership
Lords Chloro Alkali Ltd. is promoted by the S. K. Gupta Group, signifying a family-led enterprise with a substantial promoter ownership stake. Mr. Suraj Gupta is a key individual associated with the promoter group. This ownership structure typically suggests a strong, vested interest from the promoters in the long-term performance and stability of the company. The management team comprises professionals with experience in the chemical sector.
Outlook
Lords Chloro Alkali operates in a core industrial chemicals segment in India, positioned to benefit from the country's ongoing economic and industrial growth, which drives demand for its products across a diverse range of end-user industries. The company's use of efficient membrane cell technology provides a foundational advantage in cost-sensitive operations. The potential upside stems from sustained domestic demand growth, the company's ability to maintain high capacity utilization, and effective management of operational efficiencies.
However, the outlook is tempered by the inherent cyclicality of the chlor-alkali industry, significant exposure to volatile input costs (especially power), and intense competition from larger, often more integrated players. The company's performance will likely remain sensitive to macroeconomic trends, commodity price cycles, and its effectiveness in mitigating cost pressures within a competitive landscape.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 62 | 65 | 61 | 65 | 80 | 100 | 98 | 94 | 98 | 106 |
| Other Income | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 |
| Total Income | 63 | 66 | 61 | 66 | 80 | 100 | 101 | 94 | 98 | 107 |
| Total Expenditure | 60 | 60 | 57 | 59 | 70 | 80 | 80 | 83 | 84 | 84 |
| Operating Profit | 3 | 5 | 4 | 7 | 10 | 21 | 21 | 11 | 14 | 23 |
| Interest | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Depreciation | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 2 | 1 | 2 | 4 | 14 | 14 | 4 | 6 | 16 |
| Provision for Tax | 0 | 0 | 0 | 1 | 1 | 4 | 5 | -0 | 2 | 1 |
| Profit After Tax | -0 | 2 | 0 | 1 | 3 | 10 | 9 | 5 | 4 | 15 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -0 | 2 | 0 | 1 | 3 | 10 | 9 | 5 | 4 | 15 |
| Adjusted Earnings Per Share | -0 | 0.8 | 0.1 | 0.5 | 1 | 4.2 | 3.6 | 1.8 | 1.5 | 5.2 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 98 | 121 | 166 | 251 | 204 | 154 | 240 | 295 | 221 | 270 | 390 | 396 |
| Other Income | 1 | 0 | 0 | 0 | 2 | 3 | 3 | 1 | 3 | 2 | 3 | 2 |
| Total Income | 98 | 122 | 166 | 252 | 205 | 157 | 243 | 296 | 224 | 272 | 393 | 400 |
| Total Expenditure | 85 | 108 | 145 | 209 | 182 | 149 | 184 | 211 | 220 | 246 | 327 | 331 |
| Operating Profit | 14 | 13 | 21 | 42 | 23 | 8 | 59 | 85 | 4 | 26 | 66 | 69 |
| Interest | 2 | 2 | 2 | 4 | 3 | 4 | 5 | 2 | 2 | 6 | 11 | 11 |
| Depreciation | 3 | 4 | 4 | 5 | 6 | 6 | 7 | 8 | 9 | 12 | 17 | 16 |
| Exceptional Income / Expenses | -0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 8 | 15 | 34 | 14 | -2 | 47 | 75 | -7 | 8 | 39 | 40 |
| Provision for Tax | 2 | 4 | 6 | 11 | 3 | -0 | 14 | 21 | -3 | 2 | 10 | 8 |
| Profit After Tax | 7 | 4 | 8 | 23 | 10 | -2 | 32 | 53 | -5 | 6 | 28 | 33 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 4 | 8 | 23 | 10 | -2 | 32 | 53 | -5 | 6 | 28 | 33 |
| Adjusted Earnings Per Share | 3 | 1.4 | 3.4 | 9.1 | 4.1 | -0.8 | 12.8 | 21.2 | -1.9 | 2.5 | 9.9 | 12.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 44% | 10% | 20% | 15% |
| Operating Profit CAGR | 154% | -8% | 53% | 17% |
| PAT CAGR | 367% | -19% | 0% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -37% | -4% | 17% | 12% |
| ROE Average | 14% | 5% | 17% | 16% |
| ROCE Average | 14% | 6% | 19% | 16% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 41 | 44 | 52 | 75 | 86 | 84 | 116 | 169 | 164 | 182 | 243 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 50 | 51 | 68 | 63 | 42 | 36 | 30 | 6 | 25 | 78 | 96 |
| Other Non-Current Liabilities | 11 | 9 | 7 | 9 | 15 | 20 | 29 | 36 | 40 | 45 | 56 |
| Total Current Liabilities | 18 | 22 | 23 | 19 | 31 | 40 | 33 | 40 | 33 | 71 | 84 |
| Total Liabilities | 119 | 126 | 151 | 166 | 174 | 180 | 208 | 251 | 262 | 376 | 479 |
| Fixed Assets | 60 | 83 | 111 | 124 | 120 | 121 | 126 | 124 | 135 | 271 | 262 |
| Other Non-Current Assets | 20 | 7 | 4 | 4 | 4 | 7 | 7 | 24 | 41 | 19 | 74 |
| Total Current Assets | 39 | 36 | 35 | 38 | 49 | 52 | 75 | 103 | 87 | 86 | 143 |
| Total Assets | 119 | 126 | 151 | 166 | 174 | 180 | 208 | 251 | 262 | 376 | 479 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 5 | 2 | 3 | 11 | 6 | 0 | 31 | 61 | 34 | 12 |
| Cash Flow from Operating Activities | 3 | 5 | 28 | 38 | 6 | -2 | 67 | 69 | -14 | 9 | 26 |
| Cash Flow from Investing Activities | -10 | -10 | -33 | -19 | -0 | -1 | -6 | -15 | -31 | -125 | -63 |
| Cash Flow from Financing Activities | 11 | 2 | 7 | -11 | -11 | -3 | -30 | -24 | 18 | 94 | 54 |
| Net Cash Inflow / Outflow | 3 | -3 | 1 | 8 | -5 | -6 | 31 | 30 | -27 | -22 | 17 |
| Closing Cash & Cash Equivalent | 5 | 2 | 3 | 11 | 6 | 0 | 31 | 61 | 34 | 12 | 29 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.98 | 1.43 | 3.37 | 9.14 | 4.09 | -0.81 | 12.83 | 21.16 | -1.91 | 2.46 | 9.94 |
| CEPS(Rs) | 4.07 | 3.16 | 5 | 11.16 | 6.58 | 1.74 | 15.72 | 24.37 | 1.67 | 7.12 | 15.71 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 15.97 | 17.61 | 20.86 | 30.01 | 34.08 | 33.34 | 46.2 | 67.3 | 65.39 | 67.98 | 84.64 |
| Core EBITDA Margin(%) | 11.91 | 9.35 | 12.06 | 16.69 | 10.57 | 3.11 | 23.34 | 28.39 | 0.36 | 8.9 | 16.28 |
| EBIT Margin(%) | 10.04 | 7.29 | 9.95 | 14.86 | 8.24 | 1.05 | 21.37 | 26.14 | -2.39 | 5.14 | 12.81 |
| Pre Tax Margin(%) | 8.58 | 5.78 | 8.59 | 13.43 | 6.75 | -1.55 | 19.38 | 25.32 | -3.35 | 3.02 | 9.89 |
| PAT Margin (%) | 6.8 | 2.62 | 4.98 | 9.15 | 5.06 | -1.32 | 13.45 | 18.04 | -2.17 | 2.29 | 7.3 |
| Cash Profit Margin (%) | 9.29 | 5.82 | 7.39 | 11.18 | 8.12 | 2.83 | 16.47 | 20.78 | 1.9 | 6.63 | 11.54 |
| ROA(%) | 6.84 | 2.93 | 6.13 | 14.52 | 6.06 | -1.16 | 16.66 | 23.18 | -1.87 | 1.94 | 6.67 |
| ROE(%) | 20.58 | 8.49 | 17.51 | 35.94 | 12.78 | -2.41 | 32.27 | 37.28 | -2.87 | 3.68 | 13.78 |
| ROCE(%) | 11.83 | 9.26 | 14.06 | 27.39 | 11.58 | 1.11 | 34.73 | 45.88 | -2.73 | 5.46 | 14.03 |
| Receivable days | 25.86 | 26.04 | 13.25 | 9.1 | 23.3 | 45.37 | 27.1 | 16.43 | 31.3 | 42.23 | 40.97 |
| Inventory Days | 29.15 | 30.05 | 35.17 | 21.69 | 22.89 | 43.36 | 28.03 | 17.16 | 28.38 | 34.91 | 33.28 |
| Payable days | 61.32 | 15.56 | 14.42 | 4.68 | 9.23 | 21.24 | 10.76 | 7.71 | 35.17 | 41.32 | 17.3 |
| PER(x) | 9.65 | 21.71 | 14.99 | 6.89 | 4.4 | 0 | 7.4 | 6.91 | 0 | 51.28 | 10.91 |
| Price/Book(x) | 1.8 | 1.76 | 2.42 | 2.1 | 0.53 | 0.9 | 2.06 | 2.17 | 1.72 | 1.85 | 1.28 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.34 | 1.18 | 1.21 | 0.86 | 0.49 | 0.88 | 1.01 | 1.09 | 1.29 | 1.6 | 1.14 |
| EV/Core EBITDA(x) | 9.44 | 10.89 | 9.53 | 5.08 | 4.33 | 16.99 | 4.14 | 3.78 | 76.95 | 16.82 | 6.67 |
| Net Sales Growth(%) | 980.54 | 23.91 | 36.97 | 51.33 | -18.89 | -24.34 | 55.8 | 22.9 | -25.06 | 22.21 | 44.38 |
| EBIT Growth(%) | 411.85 | -9.97 | 69.84 | 120.62 | -55.02 | -90.4 | 3084.17 | 50.36 | -106.85 | 362.97 | 259.58 |
| PAT Growth(%) | 1210.9 | -52.14 | 136.23 | 171.34 | -55.2 | -119.81 | 1681.84 | 64.86 | -109.01 | 228.89 | 360.91 |
| EPS Growth(%) | 1210.85 | -52.14 | 136.22 | 171.34 | -55.2 | -119.81 | 1681.77 | 64.86 | -109.01 | 228.89 | 304.61 |
| Debt/Equity(x) | 1.57 | 1.52 | 1.46 | 0.9 | 0.71 | 0.72 | 0.3 | 0.09 | 0.22 | 0.74 | 0.67 |
| Current Ratio(x) | 2.16 | 1.65 | 1.55 | 1.98 | 1.57 | 1.3 | 2.32 | 2.6 | 2.61 | 1.21 | 1.7 |
| Quick Ratio(x) | 1.67 | 1.02 | 0.7 | 1.42 | 1.1 | 0.75 | 1.85 | 2.29 | 1.95 | 0.79 | 1.21 |
| Interest Cover(x) | 6.88 | 4.84 | 7.34 | 10.35 | 5.54 | 0.4 | 10.73 | 31.81 | -2.49 | 2.42 | 4.39 |
| Total Debt/Mcap(x) | 0.87 | 0.87 | 0.6 | 0.43 | 1.34 | 0.8 | 0.15 | 0.04 | 0.13 | 0.4 | 0.52 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.97 | 74.97 | 74.97 |
| FII | 0 | 0.03 | 0.02 | 0 | 0 | 0.07 | 0.05 | 0.01 | 0.01 | 0.07 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.17 | 0.04 | 0.04 | 0.07 | 0.09 |
| Public | 25.29 | 25.27 | 25.27 | 25.29 | 25.29 | 25.1 | 25.25 | 24.99 | 24.95 | 24.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 2.15 | 2.15 | 2.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.63 | 0.64 | 0.72 | 0.72 | 0.71 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.87 | 2.87 | 2.87 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +44% | +10% | +20% | +15% |
| Operating Profit CAGR | +154% | -8% | +53% | +17% |
| PAT CAGR | +367% | -19% | — | +15% |
| Share Price CAGR | -37% | -4% | +17% | +12% |
| ROE Average | +14% | +5% | +17% | +16% |
| ROCE Average | +14% | +6% | +19% | +16% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.66 | 74.97 | 74.97 | 74.97 |
| FII | 0 | 0.03 | 0.02 | 0 | 0 | 0.07 | 0.05 | 0.01 | 0.01 | 0.07 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.17 | 0.04 | 0.04 | 0.07 | 0.09 |
| Public | 25.29 | 25.27 | 25.27 | 25.29 | 25.29 | 25.1 | 25.25 | 24.99 | 24.95 | 24.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 2.15 | 2.15 | 2.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.63 | 0.64 | 0.72 | 0.72 | 0.71 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.87 | 2.87 | 2.87 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.